DEMSER Drug Patent Profile
✉ Email this page to a colleague
When do Demser patents expire, and when can generic versions of Demser launch?
Demser is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in DEMSER is metyrosine. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metyrosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Demser
A generic version of DEMSER was approved as metyrosine by AMNEAL on July 24th, 2020.
Summary for DEMSER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,492 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DEMSER |
| What excipients (inactive ingredients) are in DEMSER? | DEMSER excipients list |
| DailyMed Link: | DEMSER at DailyMed |
Recent Clinical Trials for DEMSER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bausch Health Americas, Inc. | Phase 2 |
| Valeant Pharmaceuticals International, Inc. | Phase 2 |
| Vanderbilt University Medical Center | Phase 3 |
Pharmacology for DEMSER
| Drug Class | Catecholamine Synthesis Inhibitor |
| Mechanism of Action | Catecholamine Synthesis Inhibitors |
US Patents and Regulatory Information for DEMSER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | DEMSER | metyrosine | CAPSULE;ORAL | 017871-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
